Mr. Damian Kettlewell reports

BLISSCO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS: FULLY CAPITALIZED FOR EXPANSION TO CONTINUE GROWING ITS GLOBAL CANNABIS ECOSYSTEM

Blissco Cannabis Corp. has released its first quarter 2018 financial results.

"Q1 was a breakthrough quarter for the Blissco's ecosystem. We closed our RTO (reverse takeover) transaction and had an oversubscribed $5.6-million investment round, started trading on the CSE (Canadian Securities Exchange), completed our construction and earned our ACMPR (Access to Cannabis for Medical Purposes Regulations) licensing by the end of March," said Damian Kettlewell, chief executive officer of Blissco Cannabis.

Throughout April, 2018, Blissco scaled up its facility and team to enable the company to meet its goal to start growing cannabis in early May, 2018. This milestone was achieved and the team also welcomed prominent advisers to assist the company expand its ecosystem and enter markets, such as the projected $196.87-billion global complementary and alternative medicine market.

In Q1 2018, the company completed its $2.9-million construction project at its 12,600-square-foot facility in Langley, B.C., which is owned by the company. In Q1 2018, Blissco Cannabis allocated $900,000 to complete this construction project. The facility is vertically integrated and optimized to be focused on distribution, branding and processing.

With its existing capital, the company will complete the outfitting of its top-of-the-line extraction lab, which will produce cannabis oils, tinctures and other high-quality products. This capital will also be used to purchase bulk cannabis for processing, as well as distribution, to medical patients and appropriate recreational jurisdictions in Canada.

The company has also initiated partnerships globally to bolster its expansion efforts worldwide.

"The company is well capitalized for the next 20 months. Our current monthly cash burn is $100,000 and we are projected to earn our sales licence amendment in early October, 2018. Thus, we anticipate revenue from medical and recreational cannabis sales to commence in October, 2018, which will generate respectable revenues before our Jan. 31, 2019, year," added Mr. Kettlewell. "We are confident we can generate significant shareholder return without diluting the current equity in the company."

About Blissco Cannabis Corp.

Blissco Cannabis owns, through its wholly owned subsidiary, Blissco Holdings Ltd., a licence to produce marijuana under the ACMPR, which was originally granted on March 29, 2018.

We seek Safe Harbor.